Invo Bioscience Stock Performance
| INVO Stock | USD 1.37 0.15 9.87% |
INVO Bioscience holds a performance score of 6 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.32, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, INVO Bioscience will likely underperform. Use INVO Bioscience potential upside, as well as the relationship between the kurtosis and day typical price , to analyze future returns on INVO Bioscience.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in INVO Bioscience are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, INVO Bioscience displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:20 | Dividend Date 2020-11-09 | Last Split Date 2023-07-28 |
1 | Acquisition by Ryan Barbara of 10435 shares of INVO Bioscience subject to Rule 16b-3 | 03/01/2024 |
2 | Insider Trading | 03/25/2024 |
3 | Short Interest in INVO Bioscience, Inc. Expands By 10.0 percent - Defense World | 04/16/2024 |
| Begin Period Cash Flow | 90.1 K |
INVO |
INVO Bioscience Relative Risk vs. Return Landscape
If you would invest 103.00 in INVO Bioscience on January 20, 2024 and sell it today you would earn a total of 49.00 from holding INVO Bioscience or generate 47.57% return on investment over 90 days. INVO Bioscience is currently generating 1.6264% in daily expected returns and assumes 18.6449% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than INVO, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
INVO Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for INVO Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as INVO Bioscience, and traders can use it to determine the average amount a INVO Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0872
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | INVO | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 18.64 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.63 actual daily | 32 68% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average INVO Bioscience is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of INVO Bioscience by adding it to a well-diversified portfolio.
INVO Bioscience Fundamentals Growth
INVO Stock prices reflect investors' perceptions of the future prospects and financial health of INVO Bioscience, and INVO Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on INVO Stock performance.
| Return On Equity | -10.61 | ||||
| Return On Asset | -0.41 | ||||
| Operating Margin | (0.91) % | ||||
| Current Valuation | 9.63 M | ||||
| Shares Outstanding | 2.74 M | ||||
| Price To Book | 5.72 X | ||||
| Price To Sales | 1.11 X | ||||
| Revenue | 3.02 M | ||||
| Gross Profit | 535.27 K | ||||
| EBITDA | (8.73 M) | ||||
| Net Income | (8.03 M) | ||||
| Cash And Equivalents | 1.96 M | ||||
| Cash Per Share | 0.16 X | ||||
| Total Debt | 9.56 M | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 1.99 X | ||||
| Book Value Per Share | 0.15 X | ||||
| Cash Flow From Operations | (4.76 M) | ||||
| Earnings Per Share | (10.34) X | ||||
| Market Capitalization | 4.99 M | ||||
| Total Asset | 20.89 M | ||||
| Retained Earnings | (57.82 M) | ||||
| Working Capital | (6.96 M) | ||||
About INVO Bioscience Performance
To evaluate INVO Bioscience Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when INVO Bioscience generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare INVO Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand INVO Bioscience market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents INVO's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 49.91 | 47.41 | |
| Return On Tangible Assets | (0.74) | (0.77) | |
| Return On Capital Employed | (0.53) | (0.56) | |
| Return On Assets | (0.38) | (0.40) | |
| Return On Equity | (9.00) | (8.55) |
Things to note about INVO Bioscience performance evaluation
Checking the ongoing alerts about INVO Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for INVO Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| INVO Bioscience is way too risky over 90 days horizon | |
| INVO Bioscience may become a speculative penny stock | |
| INVO Bioscience appears to be risky and price may revert if volatility continues | |
| INVO Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 3.02 M. Net Loss for the year was (8.03 M) with profit before overhead, payroll, taxes, and interest of 535.27 K. | |
| INVO Bioscience currently holds about 1.96 M in cash with (4.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16. | |
| INVO Bioscience has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Insider Trading |
- Analyzing INVO Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether INVO Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining INVO Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating INVO Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of INVO Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of INVO Bioscience's stock. These opinions can provide insight into INVO Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in INVO Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in INVO Stock, please use our How to Invest in INVO Bioscience guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for INVO Stock analysis
When running INVO Bioscience's price analysis, check to measure INVO Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INVO Bioscience is operating at the current time. Most of INVO Bioscience's value examination focuses on studying past and present price action to predict the probability of INVO Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INVO Bioscience's price. Additionally, you may evaluate how the addition of INVO Bioscience to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is INVO Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INVO Bioscience. If investors know INVO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INVO Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.34) | Revenue Per Share 2.043 | Quarterly Revenue Growth 3.143 | Return On Assets (0.41) | Return On Equity (10.61) |
The market value of INVO Bioscience is measured differently than its book value, which is the value of INVO that is recorded on the company's balance sheet. Investors also form their own opinion of INVO Bioscience's value that differs from its market value or its book value, called intrinsic value, which is INVO Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INVO Bioscience's market value can be influenced by many factors that don't directly affect INVO Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INVO Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if INVO Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INVO Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.